Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy era
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference112 articles.
1. IgG Fc receptors;Ravetch;Annu Rev Immunol,2001
2. Beyond binding: antibody effector functions in infectious diseases;Lu;Nat Rev Immunol,2018
3. Biology and clinical relevance of human natural killer cells;Robertson;J Am Soc Echocardiogr,2008
4. Cytotoxicity mediated by human Fc receptors for IgG;Fanger;Immunol Today,1989
5. Multiple variables at the leukocyte cell surface impact Fc γ receptor-dependent mechanisms;Patel;Front Immunol,2019
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Current Technologies and Future Perspectives in Immunotherapy towards a Clinical Oncology Approach;Biomedicines;2024-01-18
2. Circ_16601 facilitates Hippo pathway signaling via the miR-5580-5p/FGB axis to promote my-CAF recruitment in the TME and LUAD progression;Respiratory Research;2023-11-12
3. Antitumor activities against breast cancers by an afucosylated anti‐HER2 monoclonal antibody H2Mab‐77‐mG2a‐f;Cancer Science;2023-11-09
4. Adoptive cell immunotherapy for breast cancer: harnessing the power of immune cells;Journal of Leukocyte Biology;2023-11-09
5. B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancer;Breast Cancer Research;2023-10-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3